PRESS RELEASES

SEE WHAT NAT HAS TO SAY ON TOPICS IN HIV AND HIV-RELATED EVENTS

Further delays in London to essential HIV prevention drug

Monday, April 1, 2019

NHS England announced today that whilst a doubling of places on the PrEP Impact Trial (proposed on January 23) will be implemented in all participating sexual health clinics outside London, local authority commissioners in London are still considering their response to the proposed additional places.

Yusef Azad, Director of Strategy at NAT (National AIDS Trust), said: “The welcome significant uplift in PrEP trial places in the rest of the country stands in stark contrast to the delay in London's response. Over half of London's sexual health clinics are turning away gay and bisexual men in need of PrEP. Men are getting HIV as a result. We now need urgently for London's elected leaders to take ownership of this issue. We call on all of London's elected council leaders, all of London's councillors, the Mayor of London and the London Assembly to intervene to ensure PrEP is accessible to everyone who needs it in the capital.”

For more details or further comment, contact senior press officer Charlie Alderwick: charlie.alderwick@nat.org.uk 020 7814 6727

About NAT

NAT (National AIDS Trust) is the UK’s leading charity dedicated to transforming society’s response to HIV. We provide fresh thinking, expertise and practical resources. We champion the rights of people living with HIV and campaign for change.

Shaping attitudes. Challenging injustice. Changing lives.

www.nat.org.uk

NAT Topic